Principal Financial Group (PFG)

Q2 2026 Earnings Preview

Earnings Call: July 28, 2026 | Prepared: July 26, 2026 | Fiscal Period: 2Q 2026 (quarter ended June 30, 2026)

1. Earnings Preview

Key Takeaway: Setup is modestly constructive — consensus sits at a reasonable bar with Core EPS of ~$2.35 and the stock up ~35% over the past year, but the single biggest swing factor is whether Investment Management net cash flows show meaningful improvement from the deeply negative Q1 print, as any normalization there could drive upside surprise while a continued drag would weigh on sentiment.

Heading into the Q2 2026 print, the bar for PFG appears achievable but not easy. Consensus Core EPS of ~$2.35 represents a solid step-up from Q1's $2.17 (ex-significant variances) and implies continued execution on the company's 2026 financial targets, which management reaffirmed with confidence on the April call. Guidance tone was constructive: management flagged that Specialty Benefits loss ratios would "rise a bit" seasonally in Q2 given dental seasonality, but reiterated full-year loss ratios are expected to emerge at the low end or even slightly below the target range — a setup that keeps the underwriting story intact even if Q2 is modestly softer than Q1's exceptional 58.5%. Estimate revisions have been essentially flat since last earnings (Q2 consensus moved from ~$2.35 to ~$2.35), suggesting the street is not pricing in a meaningful beat or miss, which leaves the stock relatively neutral into the print. The stock has rallied ~35% over the past 12 months and ~13% over the past 3 months, with multiple expansion accounting for a meaningful portion of the move — at ~10.75x NTM P/E, valuation is no longer cheap, which raises the bar for a positive reaction. The key wildcard is Investment Management net cash flows: Q1 came in at -$2.9B (actual), driven by redemptions in a small number of U.S. active equity mutual funds; management guided for normalization through the year, and the July 20 AUM pre-release showing $808B (up ~6.4% from beginning of period) suggests market tailwinds were strong — but whether net flows actually turned less negative will be the most-watched data point on the call.

2. KPIs & Consensus Expectations

Key Takeaway: Consensus sets a reasonable but not low bar — Core EPS of ~$2.35 implies solid YoY growth, while the Specialty Benefits loss ratio is expected to tick up seasonally from Q1's exceptional 58.5%. Investment Management net cash flows remain the bigger swing factor: any improvement toward consensus expectations of ~-$5.5B (full year) would be a positive signal, while a continued deep negative print would disappoint.

Table 1 — Current Quarter Snapshot (2Q 2026)

KPI

Last Quarter Actual (1Q 2026)

Prior Year Period (2Q 2025)

2Q 2026 Consensus Estimate

YoY Change

Guidance (from 1Q26 call)

Consensus vs. Guidance

Core EPS — Diluted ($)

$2.17 (ex-sig. variances)

$2.07

$2.35

+13.5% YoY

Confident in 2026 targets; no specific Q2 EPS guide

N/A (no specific guidance)

Incurred Loss Ratio — Specialty Benefits (%)

58.5%

60.2%

~60.4%

-180 bps YoY

"Rise a bit" in Q2 (dental seasonality); full year at low end or below target range

~+190 bps vs. Q1 actual; in line with guidance

Net Cash Flows — Investment Management ($M)

-$2,900M

-$1,900M

~-$5,492M (consensus)

Worse YoY

Expects NCF profile to improve for balance of year as redemptions normalize

Consensus implies continued negative; improvement vs. Q1 would be upside

Return on Equity (%)

16.1% (non-GAAP operating)

14.1%

~14.1%

Flat YoY

Target range 15–17%

Consensus within target range

Total Revenues — Operating ($B)

$3.52B

$3.69B

~$4.02B

+8.9% YoY

No specific revenue guidance

N/A

RIS Pre-Tax Operating Earnings ($M)

$318M

$296M

~$318M

+7.4% YoY

Q1 strongest for transfer deposits; Q2 expected lighter on large case lumpiness

Consensus roughly in line with Q1 run rate

Sources: Visible Alpha consensus and actuals data for Core EPS, Net Cash Flows — Investment Management, Incurred Loss Ratio, Return on Equity, Total Revenues — Operating, and RIS Pre-Tax Operating Earnings. Q1 2026 actuals sourced from PFG Q1 2026 Earnings Release (April 23, 2026) and Q1 2026 Earnings Call transcript (April 24, 2026). Guidance from Q1 2026 Earnings Call transcript.

Table 2 — Beat/Miss History (Last 8 Quarters, Top 2 KPIs)

KPI 1: Core EPS — Diluted (ex-significant variances where applicable)

Quarter

Reported ($)

Consensus ($)

Surprise %

Result

1Q 2026

$2.17 (ex-var.)

$2.05

+5.9%

Beat

4Q 2025

$2.24

$2.25

-0.4%

In Line

3Q 2025

$2.32

$2.20

+5.5%

Beat

2Q 2025

$2.07

$2.04

+1.5%

Slight Beat

1Q 2025

$1.92

$1.88

+2.1%

Beat

4Q 2024

$2.10

$2.04

+2.9%

Beat

3Q 2024

$2.05

$2.02

+1.5%

Beat

2Q 2024

$1.92

N/A — not in VA

N/A

N/A

KPI 2: Incurred Loss Ratio — Specialty Benefits (%)

Quarter

Reported (%)

Consensus (%)

Surprise (bps)

Result

1Q 2026

58.5%

61.4%

-290 bps

Beat (lower is better)

4Q 2025

57.6%

59.3%

-170 bps

Beat

3Q 2025

56.4%

59.7%

-330 bps

Beat

2Q 2025

60.2%

N/A — not in VA

N/A

N/A

1Q 2025

60.7%

N/A — not in VA

N/A

N/A

4Q 2024

56.5%

N/A — not in VA

N/A

N/A

3Q 2024

62.7%

N/A — not in VA

N/A

N/A

2Q 2024

N/A — not in VA

N/A — not in VA

N/A

N/A

Pattern: PFG has beaten Core EPS consensus in 6 of the last 7 quarters with available data, typically by 1–6%, reflecting consistent execution. On Specialty Benefits loss ratio, the last three quarters with available consensus data all showed meaningful beats (lower-than-expected loss ratios), underscoring the strength of the underwriting franchise — though management has explicitly guided for a seasonal Q2 uptick in dental.

3. Guidance & Commentary Evolution

Key Takeaway: Guidance tone since the April 23 earnings call has been stable — no formal revisions have been issued via 8-K or conference. The July 20 AUM pre-release ($808B, +6.4% from beginning of period) is the only material post-earnings data point and is a positive read-through for fee-based revenue, but does not change formal guidance.

Metric

Initial Guidance (1Q 2026 Earnings Call, Apr 23–24)

Revised Guidance

Current Consensus

Note

2026 Financial Targets (overall)

Confident in delivering 2026 targets; EPS growth above high end of target range on ex-sig-variances basis in Q1

FY2026 Core EPS consensus ~$9.57

No post-earnings revision; tone unchanged

Specialty Benefits Loss Ratio (Q2)

"Rise a bit" in Q2 due to dental seasonality; full year at low end or slightly below target range

~60.4% (2Q26 consensus)

Consensus consistent with management’s seasonal guidance; no revision

Investment Management NCF

Expects NCF profile to improve for balance of year as redemptions normalize; commitment pipeline >$9B

FY2026 consensus ~-$10.9B

No revision; July 20 AUM pre-release ($808B) is a positive market tailwind signal

Variable Investment Income (VII)

Full year 2026 VII expected to improve vs. 2025; pickup in activity expected in Q2–Q4; no macro change needed

N/A — not separately tracked in VA consensus

Q1 had no real estate transaction activity; Q2 pickup is a key watch item

Capital Return / Dividend

$0.82/share Q2 dividend declared (8% YoY increase); ongoing share repurchases; $1.45B excess capital at Q1 end

N/A

Dividend payable June 26, 2026; capital return posture unchanged

Individual Life Segment Margin

Full year expected toward lower end of 12–16% target range; Q1 was outsized due to favorable mortality

N/A

Q1 mortality benefit unlikely to fully repeat; normalization expected in Q2

International Pension Run Rate

"Good run rate" ~mid-$70M/quarter; Q1 was elevated by $7M China Construction Bank performance fee

N/A

Q2 earnings likely to normalize from Q1’s $83M; watch for FX tailwinds given USD weakness

4. Guidance vs. Estimate Revision Tracker

Key Takeaway: Estimates have been remarkably stable since the April 23 print — 2Q 2026 Core EPS consensus moved only from ~$2.35 to ~$2.35, and FY2026 from ~$9.50 to ~$9.57, suggesting the street is tracking guidance closely with no meaningful divergence. The slight upward drift in FY EPS is consistent with Q1’s beat, but the gap is small enough that it represents cushion rather than risk.

KPI (Period)

Estimate ~5 Days Post Last Earnings (Apr 30, 2026)

Current Consensus

Estimate Δ (%)

Initial Guidance (1Q26 Call)

Current Guidance

Guidance Δ

Consensus vs. Guidance (%)

Core EPS — Diluted (2Q 2026)

$2.35

$2.35

~0%

No specific Q2 guide; confident in 2026 targets

Unchanged

N/A

Core EPS — Diluted (FY 2026)

$9.50

$9.57

+0.7%

Confident in 2026 targets; EPS growth above high end of target range in Q1

Unchanged

N/A (no specific FY EPS guide)

Incurred Loss Ratio — Specialty Benefits (2Q 2026)

~60.5%

~60.4%

-0.2%

"Rise a bit" in Q2; full year at low end or slightly below target range

Unchanged

Consensus consistent with guidance

Incurred Loss Ratio — Specialty Benefits (FY 2026)

~59.4%

~59.3%

-0.2%

Low end or slightly below target range for full year

Unchanged

Consensus tracking guidance

Net Cash Flows — Inv. Mgmt. (2Q 2026)

~-$1,553M

~-$5,492M

-254% (more negative)

NCF profile to improve for balance of year

Unchanged

Consensus more negative than guidance tone implies; improvement vs. Q1 would be upside

Net Cash Flows — Inv. Mgmt. (FY 2026)

~-$7,481M

~-$10,875M

-45% (more negative)

Expects NCF to improve through year; commitment pipeline >$9B

Unchanged

Consensus has moved more negative since earnings; gap vs. guidance tone is a risk

The most notable divergence is in Investment Management net cash flows: the post-earnings baseline consensus (~-$1.6B for Q2) has since moved to ~-$5.5B, suggesting analysts have grown more skeptical about the pace of redemption normalization. This gap between management’s constructive tone and the street’s more cautious flow estimate is the key debate heading into the print. If actual Q2 flows come in better than the -$5.5B consensus, it would be a meaningful positive catalyst.

Source: Visible Alpha consensus and actuals data. As-of date for post-earnings baseline: April 30, 2026 (approximately 5 trading days post Q1 2026 earnings release on April 23, 2026).

5. Stock Performance

Key Takeaway: The stock’s +35% 12-month gain has been driven by a roughly equal mix of multiple expansion and earnings growth — P/E expanded from ~9.3x to ~10.75x NTM while EPS estimates rose modestly. Over the past 3 months, multiple expansion (+5.3%) has been the primary driver of the +12.8% move, suggesting the stock is pricing in continued execution rather than a step-change in fundamentals.

Stock Performance Decomposition (Source: Implied platform, snapshot July 24, 2026):

Horizon

Price Return

NTM P/E at Start

NTM P/E Now

Multiple Δ

Implied EPS Growth Contribution

1 Month

+2.6%

11.46x

10.75x

-6.2%

~+9% (EPS-driven)

3 Months

+12.8%

10.20x

10.75x

+5.3%

~+7% (EPS-driven)

6 Months

+18.8%

9.65x

10.75x

+11.3%

~+7% (EPS-driven)

12 Months

+35.3%

9.26x

10.75x

+16.1%

~+19% (EPS-driven)

Current NTM multiples: P/E 10.75x | P/Book 1.73x | EV/Sales 1.35x. The 12-month rally has been roughly split between multiple re-rating (+16%) and earnings growth (~+19%), suggesting the move has been fundamentally supported. However, at 10.75x NTM P/E, the stock is no longer cheap relative to its own history (was ~9.3x a year ago), which means the print needs to deliver to sustain the current level. A miss on flows or a guidance cut would likely compress the multiple back toward the low end of the recent range.

6. Material News & Developments

Key Takeaway: The most important post-earnings development is the July 20 AUM pre-release showing $808B in total AUM as of June 30, 2026 — a ~6.4% positive impact from market performance and FX in the quarter — which is a strong tailwind for fee-based revenue and sets a constructive tone ahead of the full print.

7. Insider Transaction Activity

Key Takeaway: Insider activity since the Q1 earnings release has been limited to open-market sales by two executives — the President of Asia & Middle East and the Interim General Counsel — with no open-market purchases. The sales are discretionary (not flagged as 10b5-1 planned) and occurred in late April to late May, shortly after the Q1 earnings release. The absence of any insider buying at current levels is a mild negative signal, though the sale volumes are not unusually large relative to holdings.

Name

Title

Transaction Type

Shares

Transaction Date

Note

Cheong Wee Yee

President — Asia & Middle East

Open Market Sale

1,080 shares

Apr 29, 2026

Discretionary; reduced holdings from ~92,188 to ~91,108

Cheong Wee Yee

President — Asia & Middle East

Open Market Sale

4,737 shares

Apr 30, 2026

Discretionary; reduced holdings to ~86,371

Cheong Wee Yee

President — Asia & Middle East

Open Market Sale

9,183 shares

May 1, 2026

Discretionary; reduced holdings to ~77,188

Cheong Wee Yee

President — Asia & Middle East

Open Market Sale

3,211 shares

May 20, 2026

Discretionary; reduced holdings to ~73,977

Djurasovic George

Interim General Counsel

Open Market Sale

2,571 shares

Apr 28, 2026

Discretionary; reduced holdings to ~21,906

Djurasovic George

Interim General Counsel

Open Market Sale

~1 share (fractional)

Apr 30, 2026

Discretionary; de minimis fractional share sale

Source: SEC Form 4 filings. All transactions are open-market sales (code S / Disposition). No 10b5-1 plan flag on any transaction. No open-market purchases were filed in the period. The cluster of sales by Cheong Wee Yee (total ~18,211 shares across four transactions in late April to late May) represents a reduction of approximately 17% of his prior holdings, which is notable but not alarming given the stock’s strong run. No C-suite (CEO, CFO, COO) transactions were filed in the period.

8. Peer Commentary & Read-Throughs (Last 60 Days)

Key Takeaway: Peer commentary from Q2 2026 earnings calls and conferences paints a broadly favorable backdrop for PFG — strong market-driven AUM growth, robust asset-gathering flows (particularly in fixed income, active ETFs, and international markets), improving active equity flow trends, and accelerating private markets demand from institutional and insurance clients. The most relevant read-throughs for PFG’s Q2 print are: (1) strong market tailwinds supporting fee revenue, (2) improving but still-negative active equity flows, and (3) continued strong demand for private markets from insurers and DC plans.

Note on scope: Only commentary made in the last 60 days (on or after May 27, 2026) that speaks to Q2 2026 conditions or forward trends is included below. Retrospective commentary limited to peers’ prior-quarter results has been excluded.

BlackRock (BLK) — Q2 2026 Earnings Call (July 15, 2026)

Relevance: BLK is the world’s largest asset manager and a direct read-through for PFG’s Principal Asset Management segment on AUM trends, flow dynamics, fee rates, and private markets demand.

Ameriprise Financial (AMP) — Q2 2026 Earnings Call (July 23, 2026)

Relevance: AMP is a direct peer in wealth management, retirement, and asset management. Its Q2 2026 commentary provides the most timely and comparable read-through for PFG’s retirement and investment management segments.

Invesco (IVZ) — Morgan Stanley U.S. Financials Conference (June 10, 2026)

Relevance: IVZ is a direct peer in active asset management and provides forward-looking commentary on Q2 2026 flow trends, fee dynamics, and private markets demand that is directly applicable to PFG’s Investment Management segment.

Invesco (IVZ) — Bernstein Strategic Decisions Conference (May 27, 2026)

Relevance: Additional forward-looking commentary from IVZ CEO Andrew Schlossberg on industry trends relevant to PFG’s Q2 2026 reporting period.

Blackstone (BX) — Q2 2026 Earnings (July 23, 2026)

Relevance: BX is a read-through for private markets demand, real estate transaction activity (relevant to PFG’s Variable Investment Income recovery), and the broader alternative asset management environment.

T. Rowe Price (TROW) — ETF Innovation Commentary (July 21–22, 2026)

Relevance: TROW is a direct peer in active asset management and provides read-through on active ETF adoption trends relevant to PFG’s Investment Management segment.

Travelers (TRV) — Q2 2026 Earnings (July 17, 2026)

Relevance: TRV is a read-through for the commercial insurance and specialty benefits underwriting environment in Q2 2026, relevant to PFG’s Specialty Benefits segment.

Hartford Financial (HIG) — Q2 2026 Earnings (July 23, 2026)

Relevance: HIG is a direct peer in group benefits (disability, life, dental) and provides the most comparable read-through for PFG’s Specialty Benefits segment.

Raymond James (RJF) — Q3 FY2026 Earnings (July 22, 2026)

Relevance: RJF is a read-through for the wealth management and advisor productivity environment in Q2 2026, relevant to PFG’s wealth management build-out.

Charles Schwab (SCHW) — Q2 2026 Earnings (July 21, 2026)

Relevance: SCHW is a read-through for retail investor engagement and trading activity, relevant to PFG’s RIS and wealth management segments.

Peer Read-Through Summary Table

Peer

Date

Key Read-Through for PFG

Direction

Most Relevant PFG Segment

BlackRock (BLK)

Jul 15, 2026

Record $192B Q2 inflows; strong market tailwinds; $10B insurance private market mandates; DOL safe harbor advancing

Favorable

Investment Mgmt, RIS, Insurance

Ameriprise (AMP)

Jul 23, 2026

AUM +15% YoY; strong market appreciation; retirement & protection sales +20%; margin expansion to 43%

Favorable

Investment Mgmt, RIS, Specialty Benefits

Invesco (IVZ)

Jun 10, 2026

Q2 flows $35–36B in first 2 months; active equity flow improvement; fixed income demand broad-based globally

Favorable

Investment Mgmt (NCF)

Invesco (IVZ)

May 27, 2026

Strong April flows ($18B); personalization/SMA growth; private markets in DC is years-long build

Favorable

Investment Mgmt, RIS

Blackstone (BX)

Jul 23, 2026

Distributable earnings +26%; active real estate transactions ($8B data center, $7B battery storage); private markets retail expansion

Favorable

Variable Investment Income, Investment Mgmt

T. Rowe Price (TROW)

Jul 21–22, 2026

1/3 of all ETF flows into active products; model portfolio adoption accelerating; global ETF expansion

Favorable

Investment Mgmt (active ETFs)

Travelers (TRV)

Jul 17, 2026

Strong Q2 underwriting; pricing discipline maintained; favorable combined ratio

Favorable

Specialty Benefits

Hartford (HIG)

Jul 23, 2026

Q2 group benefits results filed; most direct peer for loss ratio read-through

Watch

Specialty Benefits (loss ratio)

Raymond James (RJF)

Jul 22, 2026

Q2 EPS beat; strong wealth management environment; advisor productivity healthy

Favorable

Wealth Management build-out

Charles Schwab (SCHW)

Jul 21, 2026

Record retail trading; client assets +22%; wealth management demand growing; AI integration advancing

Favorable

RIS, Wealth Management

Overall Peer Read-Through Assessment: The peer commentary from the last 60 days is overwhelmingly favorable for PFG’s Q2 2026 print. The key themes are: (1) strong market-driven AUM growth across the industry supports PFG’s fee revenue; (2) active equity flows are improving industry-wide, which is the most important variable for PFG’s Investment Management NCF; (3) the private markets and insurance mandate environment is robust, supporting PFG’s VII recovery and long-term private markets strategy; and (4) the underwriting environment for group benefits was favorable in Q2, supporting PFG’s Specialty Benefits segment. The one area of caution is that even with improving industry flows, PFG’s specific U.S. active equity mutual fund redemption issue is idiosyncratic and may not fully normalize in a single quarter.